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http://dxObjective: This study reviews a single-center experience with the Ross procedure in infants and young children.
Methods: From November 1993 to March 2012, 55 children aged less than 17 years underwent a Ross proce-
dure. The patients ranged in age from 2 days to 17 years (median, 5.9 years). Thirteen patients were infants, and
18 patients were preschool children. The predominant indication for the Ross procedure was aortic stenosis.
Twenty-seven patients (49%) with left ventricular outflow tract obstruction underwent a modified Ross–Konno
procedure. Twenty-five patients (45%) had undergone 40 previous cardiac procedures. Preoperatively, 3 patients
showed severe left ventricular dysfunction, with 2 of the patients requiring intubation and inotropic support.
Concomitant procedures were performed in 11 patients (20%). Nine patients underwent mitral valve surgery,
and 2 patients underwent subaortic membrane resection.
Results: Patients were followed up for a median of 66 months (range, 3 months to 17 years). Overall survival at
1, 2, 5, and 10 years was 84.9%. Hospital mortality rate was 13% (7/55 patients). All deaths occurred in neo-
nates or infants, except 1 who was aged less than 4 years. Freedom from reoperation for autograft failure was
100% at 1 year, 96.7% at 5 years, and 73.7% at 10 years. During follow-up, 7 patients required a reoperation
on the autograft for dilatation and severe aortic insufficiency. Freedom from reoperation for the right ventricular
outflow tract replacement was 56.1% at 10 years.
Conclusions: The low rate of autograft failure demonstrates that the Ross procedure is an attractive option for
the management of aortic valve disease and complex left ventricular outflow tract obstruction in the pediatric
population. However, alternative options must be considered in adolescents and young adults. (J Thorac Cardi-
ovasc Surg 2014;147:383-8)C
H
DThe optimal operative management of aortic valve disease
in children and young adults remains controversial. The
Ross operation, first described more than 40 years ago, is
aimed at the treatment of aortic valve disease and based
on autograft transplantation of the native pulmonary valve
into the aortic position and reconstruction of the pulmonary
outflow tract with an homograft.1 The Ross operation al-
lows growth of the autograft and avoidance of anticoagula-
tion therapy.2 However, because the need for multiple
reinterventions for the replacement of the right ventricular
outflow tract (RVOT) substitute and neoaortic root dilata-
tion leading to aortic regurgitation have been reported,3-5
one could argue that the Ross procedure might turn
a single-valve disease into a double-valve pathology.6
The goal of this study was to report a single-institution
experience with the Ross operation in neonates, infants,e Department of Cardiac Surgery, Ospedale Pediatrico Bambino Gesu,
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The Journal of Thoracic and Cachildren, and young adults and to describe the incidence
of pulmonary autograft dilation and insufficiency, as well
as the need for reintervention on the autograft or homograft.MATERIALS AND METHODS
The Committee on Clinical Investigation at Bambino Gesu Children’s
Hospital approved the study and waived the requirement for written in-
formed consent.
Subjects
Between November 1993 andMarch 2012, all patients aged less than 18
years who underwent a Ross procedure at the Bambino Gesu Children’s
Hospital were included. All patients underwent surgery with the standard
technique of cardiopulmonary bypass with bicaval cannulation and moder-
ate hypothermia. Myocardial protection was achieved by intermittent infu-
sion of blood cardioplegia.
A standard technique of complete root replacement with coronary trans-
fer was used for the Ross procedure. No pledgets were used. In case of left
ventricular outflow tract (LVOT) obstruction, a modified Ross–Konno pro-
cedurewas performed. The ventriculoplasty incision was patched by an ex-
tension of attached infundibular free wall muscle harvested with the
autograft. A pulmonary/aortic homograft or a heterograft was used for
RVOT reconstruction.
The primary outcome measure was the need for late reintervention. The
secondary outcome variables were represented by 28-daymortality and late
survival, late right ventricle to pulmonary artery (RV-PA) conduit, and au-
tograft failure. For the purpose of this analysis, RV-PA failure was defined
as the presence of insufficiency or stenosis of the conduit with a mean gra-
dient of at least 30 mm Hg and right ventricular pressure at least 2/3 tordiovascular Surgery c Volume 147, Number 1 383
Abbreviations and Acronyms
CI ¼ confidence interval
LVOT ¼ left ventricular outflow tract
RVOT ¼ right ventricular outflow tract
RV-PA ¼ right ventricle to pulmonary artery
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Drespect the systemic arterial pressure; autograft failure was defined as neo-
aortic root dilatation with z score changes from hospital discharge to
follow-up or changes in neoaortic valve insufficiency grade from discharge
to follow-up.
The immediate postoperative result was assessed by transesophageal
echocardiography in all patients after surgery. Further echocardiography
studies were obtained preoperatively, postoperatively, and annually there-
after. Autograft valve function, homograft or RVOT conduit valve function,
and left ventricular function were assessed by M-mode, 2-dimensional
echocardiography and color flow Doppler.
Statistical Analysis
STATAversion 11.1 data analysis and statistical software (StataCorp LP,
College Station, Tex) was used for statistical analysis. Continuous variables
are reported as median (range), and categoric variables are reported as
number (proportion). The t test and Wilcoxon rank-sum test were used
for continuous variables as appropriate; the chi-square and Fisher exact
tests were used for categoric variables as appropriate. Survival curves for
freedom from RV-PA, autograft failure, and late survival were obtained
by use of the Kaplan–Meier method, and comparisons were performed
with the log-rank test. The continuous variables examined included age
and weight at treatment, which were dichotomized at a cutoff of 1 year
and 10 kg, respectively, to explore the effect of younger age and low
body weight on outcomes. Additional multivariate survival analyses for
the separate end points of RV-PA and autograft failure or late survival
were performed by means of Cox proportional hazards multiple regression
models. The selection of independent variables for the model was based on
statistical significance in univariable testing. All comparisons were
2-sided.RESULTS
A total of 55 patients underwent the Ross operation at the
Ospedale Pediatrico Bambino Gesu during the study period.
Demographic and selected operative characteristics for
these patients are summarized in Table 1. Median age and
weight at surgery were 5.9 years (range, 2 days-17 years)
and 18 kg (range, 3.5-110), respectively. Follow-up infor-
mation was available for 74% of the 55 patients. Median
follow-up time was 66 months (range, 3 months to 17
years).
The preoperative hemodynamic indication for the Ross
procedurewas represented by a combination of aortic steno-
sis and regurgitation for 31 patients (56%). In 27 patients
(51%) with LVOT obstruction, a modified Ross–Konno
procedure was performed. In 2 patients with Shone’s anom-
aly, concomitant mitral valve surgery was required.
Twenty-five patients (47%) had undergone a total of
40 previous cardiac procedures. These procedures are
listed in Table 1. Three patients (5.5%) showed severe384 The Journal of Thoracic and Cardiovascular Surgpreoperative left ventricular dysfunction; of those, 2
patients required preoperative mechanical ventilation and
inotropic support.
Whenever possible, a pulmonary homograft (31 patients,
51%) was preferentially used to reconstruct the RVOT. An
aortic homograft was used in 3 patients (6%), and a hetero-
graft was used in 23 patients (42%). The median diameter
of the replaced pulmonary valve was 19 mm (range,
10-26 mm).
Concomitant procedures were performed in 11 patients.
A concurrent mitral valve surgery was performed in 9 pa-
tients (17%); of those, 6 patients underwent mitral repair
and 3 patients underwent valve replacement. The remaining
2 patients underwent subaortic membrane resection. Two
patients who underwent the Konno–Ross operation required
insertion of a permanent pacemaker for a complete atrio-
ventricular block.
Twenty-Eight–Day Mortality and Late Survival
Seven patients (13%) died within 28 days from surgery.
Three patients were neonates, 3 patients were infants, and 1
patient was a preschool child. Of those patients, 1 showed
signs of aortic valve endocarditis with severe insufficiency
and died of multiple organ failure. Six patients underwent
a Ross–Konno procedure, with concomitant mitral valve
surgery in 2. Two neonates with critical aortic valve stenosis
underwent urgent Ross operation for severe aortic insuffi-
ciency after balloon valvuloplasty.
At the univariate level, age less than 1 year, weight less
than 10 kg at surgery, and longer cardiopulmonary bypass
time were associated with 28-day mortality (Table 2). Be-
cause the number of events was low, it was not possible to
seek an independent association between demographic vari-
ables and 28-day mortality by using a multivariable logistic
regression model.
Overall survival at 1, 2, 5, and 10 years was 84.9%
(range, 72.1%-92.2%) (Figure 1). We were not able to
identify any independent association between perioperative
characteristics and late survival (Table 3).
Late Reintervention
Overall freedom from all-cause reoperation was 97.6%
(range, 84.6%-99.7%), 86.7% (range, 70.7%-94.3%),
and 48.1% (range, 27.2%-66.2%) at 1, 5, and 10 years,
respectively (Figure 2).
Reoperations on the Autograft
Overall freedom from reoperation for autograft failure
was 100%, 96.7% (range, 78.6%-99.5%), and 73.7%
(range, 47.2%-88.4%) at 1, 5, and 10 years, respectively.
Six patients (11%) required reoperation on the autograft;
the main mechanism was represented by severe aortic insuf-
ficiency in 5 patients and aortic root dilatation in 1 patient.
One patient required simultaneous reoperation of both theery c January 2014
TABLE 1. Patient demographics and preoperative characteristics of
the study population (n ¼ 55)
Variable Median (range) or N (%)
Age 5.9 y (2 d to 17 y)
Neonates (<1 mo) 4 (7)
Infants (<12 mo) 9 (16)
Preschool child (1-5 y) 18 (33)
Child (5-10 y) 9 (16)
Adolescent (10-17 y) 15 (27)
Weight at surgery (kg) 18 (3.5-110)
Gender (M/F) 39/16
Redo operation 25 (45)
Aortic balloon valvuloplasty 20 (36)
Surgical valvotomy 4 (7)
Surgical valvuloplasty 2 (4)
Coarctation repair or aortic arch plasty 13 (24)
Subaortic membrane resection 7 (13)
VSD repair 3 (5)
VSD repair and coarctation repair 2 (4)
Mitral valve surgery 3 (5)
IAA-A repair/IAA-B repair and VSD repair 3 (5)
Others 4 (7)
Preoperative aortic valve disease
Mixed AS/AI 31 (56)
AS 14 (25)
AI 8 (15)
Bicuspid aortic valve 15 (27)
VSD, Ventricular septal defect; IAA, aortic arch interruption; AS, aortic stenosis;
AI, aortic insufficiency.
FIGURE 1. Kaplan–Meier survival curve for 55 patients undergoing Ross
operation. Shaded areas indicate 95% confidence intervals (CIs).
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Dautograft and the homograft. All patients received a me-
chanical valve replacement except 1 patient who underwent
aortic valve repair. Two additional patients affected by au-
tograft valve insufficiency were waiting for reoperation at
the time of the study. Multivariable analyses showed that
aortic steno-insufficiency is independently associated with
an increased risk of autograft failure (Table 4 and
Figure 3). Autograft failure is a time-related event, with
a significant late hazard 12 years after Ross surgery
(Figure 4).TABLE 2. Univariate analysis of demographic and selected
perioperative characteristics and 28-day mortality
Risk factors 28-d mortality P
Age<1 y <.001










The Journal of Thoracic and CaReoperations on the Right-Sided Conduit
Twelve patients (22%) required RV-PA conduit reopera-
tions; of those, 2 patients required 2 reoperations. The indi-
cation for conduit reintervention was predominant stenosis
in all patients. Overall freedom from reoperation for the
RVOT replacement was 97.7% at 1 year, 89.7% at 5 years,
and 56.1% at 10 years. Univariate and multivariate analyses
showed that the use of a heterograft for RVOT reconstruc-
tion compared with the use of a homograft was associated
with increased hazards to undergo late reoperation
(Table 4 and Figure 5).
DISCUSSION
The Ross operation is a double root procedure that has the
advantages of a viable neoaortic root with excellent hemo-
dynamics, freedom from hemolysis, potential of growth in
infants and young children, and a low risk of endocarditis.7
The operation requires reconstruction of the RVOT with
a nonviable valve and is a technically demanding procedure
with an increased operative risk and concerns for long-term
durability. The early postoperative mortality rates reported
in the literature are low, ranging from 1.5% to 3.5% in
larger series.8,9 We reported a slightly higher 28-day mor-
tality rate (13%) compared with reports from other cen-
ters.10,11 We believe this difference is mainly due to the
younger age of our cohorts at surgery; the median age at
surgery was 5.9 years, and 25% of patients were aged
less than 1 year and 60% of patients were aged less than
5 years. Six of 7 patients who died in our cohort were
aged less than 1 year. Preoperative severe hemodynamic
impairment as shown by the need of urgent Ross
operation in 2 neonates also plays a major role in
increasing the likelihood of early mortality. Moreover, the
concomitant high rate of Konno modification among
patients who died early may suggest that postoperative
myocardial dysfunction significantly contributed to therdiovascular Surgery c Volume 147, Number 1 385
TABLE 3. Risk factors for late survival and late intervention: Results of univariable and multivariable analysis
Risk factors
Unadjusted Adjusted
Late survival P Late reintervention P Late survival* P Late reintervention* P
Age<1 y <.001 .83 – –
Weight at surgery<10 kg <.001 .61 – –
Sex .83 .31 – –
Diagnosis
Aortic stenosis .23 .26 – –
Aortic steno-insufficiency
Aortic insufficiency
Mitral lesion .82 .53 – –
Conduit type (heterograft vs homograft) .05 .02 – 3.51 (1.14-10.76)
0.03
*Hazard ratio (95% CI).
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Dhigher mortality rate in our cohort of patients. Our data
confirm that younger age, weight at surgery, and longer
bypass time are associated with early mortality.12
The Ross procedure is an advantageous approach to re-
lieve the hypoplastic aortic annulus.13 The excellent expo-
sure of the LVOT and the ventricular septum facilitates
the enlargement of the Konno modification. In our series,
27 patients had a concomitant Konno procedure; no resteno-
sis of LVOT was observed during follow-up. Nine patients
with LVOT obstruction and mitral valve disease underwent
a Ross–Konno procedure with concomitant mitral valve
surgery. Because 3 valves may be at risk for postoperative
complications, concomitant mitral valve surgery at the
time of the Ross procedure is thought to be associated
with a poor outcome.13,14 In our series, we could not
confirm the association between mitral valve disease and
early mortality. On the basis of our data, we believe that
combining the Ross procedure and mitral valve surgery is
a feasible and safe surgical approach.
The rate of structural and nonstructural autograft deteri-
oration with the need for reoperation in pediatric patientsFIGURE 2. Kaplan–Meier freedom from all-cause reoperation. Shaded
areas indicate 95% CIs.
386 The Journal of Thoracic and Cardiovascular Surgranges from 0.24% to 2.82% per patient-year, with a pooled
mean of 1.38% per patient-year.15 In our cohort, freedom
from reoperations on the autograft was 96.7% at 5 years
and 90% at 8 years. However, autograft failure becomes ap-
parent after 12 years in accordance with an actuarial esti-
mate of 73%. Aortic regurgitation was the leading cause
of reoperation based on nonstructural valve failure with
root dilatation. A systematic review of the literature con-
ducted by Takkenberg and colleagues15 showed that youn-
ger age may be associated with decreased autograft
durability. This study also showed that significant variabil-
ity between studies in terms of autograft deterioration was
present and suggested that some of the variability may be
due to differences in surgical techniques. In our study, the
root replacement technique was used in all patients, using
a maximum of 1 to 2 mm of muscle below the valve and
in some cases an additional reinforcement of the aortic an-
nulus with a strip of autologous pericardium. We believe
this technique might help prevent annular dilatation. We
do not use any other form of stabilization (ie, putting the au-
tograft into the Valsalva tube) to facilitate the growth of the
autograft.
The incidence of structural and nonstructural degenera-
tion of conduit was reported to be 1.6% per patient-year,
ranging from 0.7% to 3% in pediatric series.15 In our series,
freedom from pulmonary valve replacement after the Ross
procedure was 56.1% at 10 years of follow-up. All patients
underwent RVOT conduit replacement for conduit stenosis
secondary to outgrowth or degeneration. Our results indi-
cate that reoperation for conduit replacement is likely to
be necessary during late childhood or adolescence. On the
basis of our data showing the higher durability of a homo-
graft compared with a heterograft for RVOT reconstruction,
our policy is now to use a pulmonary homograft for RVOT
reconstruction and to place the largest possible conduit at
the time of the operation.
The Ross operation has demonstrated excellent results in
both children and adults.9,10,16 In particular, given the
possibility of autograft growth, the Ross operation isery c January 2014
TABLE 4. Risk factors for late right ventricle to pulmonary artery and autograft failure: Results of univariable and multivariable analysis
Risk factors
Unadjusted Adjusted
RV-PA conduit failure P Autograft failure P RV-PA conduit failure* P Autograft failure* P
Age<1 y .47 .65 – –
Weight at surgery<10 kg .44 .53 – –
Sex .12 .31 – –
Diagnosis .17 .04
Aortic stenosis (Reference)
Aortic steno insufficiency 6.28 (1.14-34.66)
Aortic insufficiency .03
Mitral lesion .35 .47 – –
Conduit type (homograft vs heterograft) .004 – 4.24 (1.16-15.47)
0.03
–
*Hazard ratio (95% CI).
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Dconsidered the surgical procedure of choice for neonates
and infants.12,17 Complex aortic valve repair has been
described in infants with respectable intermediate-term re-
sults.18 Nonetheless, as a result of the unique technical chal-
lenges posed by small infants, the Ross operation still
remains the more effective surgical solution in this popula-
tion. Furthermore, 51% of patients in our cohort required
a Konno modification to address LVOT obstruction, which
would not be treated by aortic valve repair alone. By con-
trast, alternative surgical options with comparable long-
term results (eg, aortic valve repair and valve replacement
with stentless valves or bioprosthesis) are available for ad-
olescents and young adults.19,20 Nonetheless, some authors
argue that the Ross operation might place 2 valves at risk for
single valve disease.6,21 There have been an increasing
number of reports describing dilatation of the aortic
annulus, sinuses of Valsalva, and sinotubular junction
after the Ross procedure.4,22 Histologic studies have
demonstrated that the pulmonary wall can show fracture
and a general disorganization of elastin fibers whenFIGURE 3. Kaplan–Meier freedom from autograft failure according to
preoperative aortic lesion. Shaded areas indicate 95% CIs.
The Journal of Thoracic and Caexposed to the high-pressure systemic circulation.23 On
the other hand, Yacoub and El-Hamamsy24 describe ‘‘bio-
mechanics and maintained viability of the aortic root after
aortic valve replacement are major determinants of long-
term outcomes.’’ In particular, the native aortic root is a dy-
namic living structure that undergoes active changes in size
and shape during the cardiac cycle, so that the Ross proce-
dure is the only operation that guarantees long-term viabil-
ity of the aortic valve.24 In our experience, the Ross
operation has demonstrated excellent outcome within the
first decade after surgery followed by an increased rate of
reoperation in the second decade. Our institutional policy
for aortic valve disease is based on the Ross procedure for
infants, neonates, and children, and aortic valve repair or
aortic valve replacement with bioprosthesis or stentless in
adolescents or young adults.
CONCLUSIONS
Our data show that the Ross procedure is an attractive op-
tion for the management of aortic valve disease and com-
plex LVOT obstruction in a pediatric population with high
long-term survival. However, a high early mortality rate
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FIGURE 5. Kaplan–Meier freedom from RV-PA conduit failure. Shaded
areas indicate 95% CIs. RV-PA, Right ventricle to pulmonary artery.
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Dprocedure in infants or in case of multilevel left-sided heart
obstructions. The use of a heterograft and the presence of
aortic steno-insufficiency are independently associated
with RV-PA conduit and autograft failure, respectively.
The rate of reoperation for autograft failure is low and en-
couraging especially within the first decade after surgery.
By contrast, the high rate of reoperation for a right-sided
conduit in childhood and adolescence should favor alterna-
tive surgical options, such as aortic valve repair or
replacement.References
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